| BID | 121.18 | ASK | 121.26 | ||
| Open | 121.19 | Previous Close | 123.08 | ||
| Pre-Market | 122.20 | After-Market | - | ||
| -0.88 -0.71% | - - |
| Target Price | 157.80 | Analyst Rating | Strong Buy 1.44 | |
| Potential % | 30.33 | Finscreener Ranking | ★+ 43.88 | |
| Insiders Trans % 3/6/12 mo. | -100/-100/-100 | Value Ranking | ★★ 45.65 | |
| Insiders Value % 3/6/12 mo. | -100/-100/-100 | Growth Ranking | ★★★★ 59.13 | |
| Insiders Shares Cnt. % 3/6/12 mo. | -100/-100/-100 | Income Ranking | ★★ 39.79 | |
| Price Range Ratio 52W % | 12.80 | Earnings Rating | Sell | |
| Market Cap | 36.38B | Earnings Date | 24th May 2022 | |
| Alpha | 0.01 | Standard Deviation | 0.07 | |
| Beta | 1.06 |
Today's Price Range 120.57121.91 | 52W Range 112.64179.57 | 5 Year PE Ratio Range 9.1078.10 |
Summary:
Neutral
| Technical Indicators: | Neutral |
| Moving Averages: | Sell |
| Performance | |||
|---|---|---|---|
| 1 Week | 7.97% | ||
| 1 Month | -0.61% | ||
| 3 Months | -6.79% | ||
| 6 Months | -24.10% | ||
| 1 Year | -4.40% | ||
| 3 Years | 78.09% | ||
| 5 Years | 120.38% | ||
| 10 Years | 359.29% |
| Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
ROE (5Y Avg) | 12.55 | |||
ROE last 12 Months | 25.11 | |||
ROA (5Y Avg) | 6.11 | |||
ROA last 12 Months | 12.50 | |||
ROC (5Y Avg) | 9.72 | |||
ROC last 12 Months | 17.15 | |||
Return on invested Capital Q | 3.76 | |||
Return on invested Capital Y | 5.85 | |||
Assets Turnover | 0.50 | |||
Receivables Turnover | 4.50 |
| Valuation | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 30.40 | ||||
| 6.95 | ||||
| 7.34 | ||||
| 24.30 | ||||
| 54.70 | ||||
| 4.92 | ||||
| 137.27 | ||||
| 17.17 | ||||
| 37.40B | ||||
| Forward PE | 22.52 | |||
| PEG | 3.38 |
| Financial Strength | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 1.50 | ||||
| 2.20 | ||||
| 0.35 | ||||
| 0.53 | ||||
| 17.50 | ||||
| Leverage Ratio | 2.00 |
| Profitability | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 54.00 | ||||
| 22.50 | ||||
| 27.60 | ||||
| 19.60 | ||||
| 19.98 |
| Revenue | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 4.92B | ||||
| 16.39 | ||||
| 4.82 | ||||
| 6.15 |
| Dividends | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 0.70 | ||||
| 0.84 | ||||
| 7.81 | ||||
| 9.89 | ||||
| Payout ratio | 25.00 |
| Earnings History | Estimate | Reported | Surprise % |
|---|---|---|---|
| Q01 2022 | 1.17 | 1.21 | 3.42 |
| Q04 2021 | 1.17 | 1.21 | 3.42 |
| Q03 2021 | 0.99 | 1.10 | 11.11 |
| Q02 2021 | 0.82 | 0.97 | 18.29 |
| Q01 2021 | 0.89 | 1.06 | 19.10 |
| Q04 2020 | 0.91 | 0.98 | 7.69 |
| Q03 2020 | 0.66 | 0.78 | 18.18 |
| Q02 2020 | 0.58 | 0.71 | 22.41 |
| Earnings Per End | Estimate | Revision % | Trend |
|---|---|---|---|
| 4/2022 QR | 1.11 | -0.89 | Negative |
| 7/2022 QR | 1.20 | 0.00 | - |
| 10/2022 FY | 4.86 | 0.83 | Positive |
| 10/2023 FY | 5.34 | 0.75 | Positive |
| Next Report Date | 24th May 2022 |
| Estimated EPS Next Report | 1.11 |
| Estimates Count | 7 |
| EPS Growth Next 5 Years % | 9.00 |
| Volume Overview | |
|---|---|
| Volume | 663.22K |
| Shares Outstanding | 300.11K |
| Shares Float | 299.34M |
| Trades Count | 13.65K |
| Dollar Volume | 80.49M |
| Avg. Volume | 1.93M |
| Avg. Weekly Volume | 1.61M |
| Avg. Monthly Volume | 2.02M |
| Avg. Quarterly Volume | 2.17M |
Agilent Technologies Inc. (NYSE: A) stock closed at 123.08 per share at the end of the most recent trading day (a 2.31% change compared to the prior day closing price) with a volume of 2.21M shares and market capitalization of 36.38B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 16700 people. Agilent Technologies Inc. CEO is Michael R. McMullen.
The one-year performance of Agilent Technologies Inc. stock is -4.4%, while year-to-date (YTD) performance is -22.91%. A stock has a five-year performance of 120.38%. Its 52-week range is between 112.64 and 179.57, which gives A stock a 52-week price range ratio of 12.80%
Agilent Technologies Inc. currently has a PE ratio of 30.40, a price-to-book (PB) ratio of 6.95, a price-to-sale (PS) ratio of 7.34, a price to cashflow ratio of 24.30, a PEG ratio of 2.32, a ROA of 12.50%, a ROC of 17.15% and a ROE of 25.11%. The company’s profit margin is 19.98%, its EBITDA margin is 27.60%, and its revenue ttm is $4.92 Billion , which makes it $16.39 revenue per share.
Of the last four earnings reports from Agilent Technologies Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $1.11 for the next earnings report. Agilent Technologies Inc.’s next earnings report date is 24th May 2022.
The consensus rating of Wall Street analysts for Agilent Technologies Inc. is Strong Buy (1.44), with a target price of $157.8, which is +30.33% compared to the current price. The earnings rating for Agilent Technologies Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Agilent Technologies Inc. has a dividend yield of 0.70% with a dividend per share of $0.84 and a payout ratio of 25.00%.
Agilent Technologies Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 10.26, ATR14 : 4.25, CCI20 : 55.33, Chaikin Money Flow : 0.03, MACD : -2.54, Money Flow Index : 65.06, ROC : 3.19, RSI : 50.58, STOCH (14,3) : 74.31, STOCH RSI : 1.00, UO : 49.47, Williams %R : -25.69), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Agilent Technologies Inc. in the last 12-months were: Dominique Grau (Option Excercise at a value of $1 105 639), Dominique Grau (Sold 30 768 shares of value $4 791 898 ), Henrik Ancher-Jensen (Option Excercise at a value of $2 027 024), Henrik Ancher-Jensen (Sold 87 462 shares of value $12 565 052 ), Jacob Thaysen (Sold 16 289 shares of value $2 327 698 ), Michael R. McMullen (Sold 123 459 shares of value $18 373 168 ), Michael Tang (Sold 14 675 shares of value $1 998 165 ), Padraig McDonnell (Sold 4 000 shares of value $633 420 ), Rodney Gonsalves (Sold 3 168 shares of value $501 479 )
Agilent Technologies Inc.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2020 sales), cross lab (36% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Just over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (33%) and China (20%) representing the largest country concentrations.
CEO: Michael R. McMullen
Telephone: +1 800 227-9770
Address: 5301 Stevens Creek Boulevard, Santa Clara 95051, CA, US
Number of employees: 16 700
